Navco Pharmaceuticals (FRA:F0U) ROCE %: 0.00% (As of Mar. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Navco Pharmaceuticals ROCE %?

Navco Pharmaceuticals FRA:F0U ROCE % is 0.00% as of Mar. 2023.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Navco Pharmaceuticals's annualized ROCE % for the quarter that ended in Mar. 2023 was 0.00%.

Navco Pharmaceuticals  (FRA:F0U) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Navco Pharmaceuticals ROCE % Related Terms

Navco Pharmaceuticals ROCE % Historical Data

* Premium members only.

The historical data trend for Navco Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Navco Pharmaceuticals ROCE % Chart

Navco Pharmaceuticals Annual Data
Trend Jun18 Jun19 Jun20 Jun21
ROCE %
0.00 -120.00 -26.83 -62.79

Navco Pharmaceuticals Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -61.54 -738.46 -800.00 0.00 0.00

Navco Pharmaceuticals ROCE % Calculation

Navco Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Jun. 2021 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2021 )  (A: Jun. 2020 )(A: Jun. 2021 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2021 )  (A: Jun. 2020 )(A: Jun. 2021 )
=-0.054/( ( (0.119 - 0.013) + (0.079 - 0.013) )/ 2 )
=-0.054/( (0.106+0.066)/ 2 )
=-0.054/0.086
=-62.79 %

Navco Pharmaceuticals's ROCE % of for the quarter that ended in Mar. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2023 )  (Q: Dec. 2022 )(Q: Mar. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2023 )  (Q: Dec. 2022 )(Q: Mar. 2023 )
=0.02/( ( (0.065 - 0.068) + (0.065 - 0.062) )/ 2 )
=0.02/( ( -0.003 + 0.003 )/ 2 )
=0.02/0
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Navco Pharmaceuticals (FRA:F0U) has a ROCE % of 0.00% as of Mar. 2023.
Is Navco Pharmaceuticals' ROCE % too high?
Navco Pharmaceuticals' current ROCE % is 0.00%.
How does Navco Pharmaceuticals' ROCE % compare to ZTS and VTRS?
Navco Pharmaceuticals' ROCE % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Navco Pharmaceuticals's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Navco Pharmaceuticals stock overvalued right now?
Navco Pharmaceuticals (FRA:F0U) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Navco Pharmaceuticals (FRA:F0U), the current ROCE % is 0.00% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Navco Pharmaceuticals Business Description

Address 1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7
Navco Pharmaceuticals Inc is engaged in creating nanotechnology products using computer algorithms. The products are used in various industries like medicine, textiles, chemicals, and additives to combat microorganisms such as viruses and bacteria. Its products include aerosol sprays, hand cleansers, hand creams, and nano BioGuard(tm)-Silver.